You are here:
Publication details
Safety and tolarability of 96 weeks of tenofovir disoproxil fumarate (TDF) treatment in HBeAg negative and positive patients infected with chronic hepatitis B (CHB)
Authors | |
---|---|
Year of publication | 2009 |
Type | Article in Periodical |
Magazine / Source | Gastroenterology |
MU Faculty or unit | |
Citation | |
Field | Epidemiology, infectious diseases and clinical immunology |